Key facts
- This page summarizes Wesley S. Lobo's Form 4 filing for NEPHROS INC (NEPH).
- 1 reported transaction and 2 derivative rows are listed below.
- Accepted by SEC: 18 Feb 2022, 16:03.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Tax liability
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
The reporting person has elected to satisfy his tax withholding obligation in connection with the vesting of a prior restricted stock grant by directing the Company to withhold shares otherwise issuable upon vesting of the previously reported grant.
Footnote F2
Includes 15,000 shares of restricted stock for which the risk of forfeiture will lapse as to 5,000 shares on each of 2/16/23, 2/16/24 and 2/16/25.
Footnote F3
Options to purchase 28,545 shares vest on 2/16/22 and options to purchase 85,633 shares vest quarterly in 12 equal amounts commencing on 5/16/22.
Footnote F4
Options to purchase 14,342 shares vest on 9/1/22 and options to purchase 43,026 shares vest quarterly in 12 equal amounts commencing on 12/1/22.